Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Roth

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
Journal of Neurochemistry|May 13, 2011
A specific miRNA signature in the peripheral blood of glioblastoma patientsPatrick Roth, Jörg Wischhusen, Caroline Happold, et al.
Neurology|February 19, 2014
Clinical reasoning: a 30-year-old woman with recurrent seizures and a cerebral lesion progressing over 2 decadesMichaela Tonder, Elisabeth Jane Rushing, Michael Grotzer, et al.
Neuro-Oncology Practice|October 5, 2020
Antidepressant drug use in glioblastoma patients: an epidemiological viewDorothee Gramatzki, James Louis Rogers, Marian Christoph Neidert, et al.
Neuro-Oncology|November 11, 2020
The molecular evolution of glioblastoma treated by gross total resection aloneDorothee Gramatzki, Jörg Felsberg, Patrick Roth, et al.
Science Translational Medicine|October 8, 2020
Immunocytokines are a promising immunotherapeutic approach against glioblastomaTobias Weiss, Emanuele Puca, Manuela Silginer, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2014
Addition of lomustine for bevacizumab-refractory recurrent glioblastomaMichaela Tonder, Günter Eisele, Tobias Weiss, et al.
Journal for Immunotherapy of Cancer|February 4, 2026
Potent antitumor activity through dual targeting of PD-L1 and TGF-β pathways in the glioma tumor microenvironmentManuela Silginer, Michael Weller, Burkhard Becher, et al.
Multiple Sclerosis and Related Disorders|July 5, 2025
Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide surveyLukas Steinegger, Veronika Kana, Caroline Pot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 7, 2023
Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated diseaseLaura Skarsta, Tommaso Nicoletti, Katja Frick, et al.
Acta Neuropathologica Communications|March 14, 2023
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibitionManuela Silginer, Eleanna Papa, Emese Szabó, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
Journal of Neurochemistry|May 13, 2011
A specific miRNA signature in the peripheral blood of glioblastoma patientsPatrick Roth, Jörg Wischhusen, Caroline Happold, et al.
Neurology|February 19, 2014
Clinical reasoning: a 30-year-old woman with recurrent seizures and a cerebral lesion progressing over 2 decadesMichaela Tonder, Elisabeth Jane Rushing, Michael Grotzer, et al.
Neuro-Oncology Practice|October 5, 2020
Antidepressant drug use in glioblastoma patients: an epidemiological viewDorothee Gramatzki, James Louis Rogers, Marian Christoph Neidert, et al.
Neuro-Oncology|November 11, 2020
The molecular evolution of glioblastoma treated by gross total resection aloneDorothee Gramatzki, Jörg Felsberg, Patrick Roth, et al.
Science Translational Medicine|October 8, 2020
Immunocytokines are a promising immunotherapeutic approach against glioblastomaTobias Weiss, Emanuele Puca, Manuela Silginer, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2014
Addition of lomustine for bevacizumab-refractory recurrent glioblastomaMichaela Tonder, Günter Eisele, Tobias Weiss, et al.
Journal for Immunotherapy of Cancer|February 4, 2026
Potent antitumor activity through dual targeting of PD-L1 and TGF-β pathways in the glioma tumor microenvironmentManuela Silginer, Michael Weller, Burkhard Becher, et al.
Multiple Sclerosis and Related Disorders|July 5, 2025
Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide surveyLukas Steinegger, Veronika Kana, Caroline Pot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 7, 2023
Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated diseaseLaura Skarsta, Tommaso Nicoletti, Katja Frick, et al.
Acta Neuropathologica Communications|March 14, 2023
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibitionManuela Silginer, Eleanna Papa, Emese Szabó, et al.
Pageof 23